SCHEMBL6272716

SCHEMBL6272716

CC(C)=CCOc1c(O)c2cc(OCCO)ccc2oc1=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 3/20 0.46
▸ L3MBTL1 Q9Y468 2/20 0.46
▸ TSHR P16473 1/20 0.46
▸ ALDH1A1 P00352 5/20 0.46
▸ KDM4E B2RXH2 5/20 0.46
▸ MTNR1A P48039 2/20 0.46
▸ MAPT P10636 3/20 0.45
▸ HPGD P15428 3/20 0.45
▸ GAA P10253 2/20 0.45
▸ NQO1 P15559 1/20 0.44
▸ MGAM O43451 1/20 0.43
▸ SI P14410 1/20 0.43
▸ PTPN1 P18031 1/20 0.43
▸ MGAM2 Q2M2H8 1/20 0.43
▸ LMNA P02545 1/20 0.42
▸ ACHE P22303 1/20 0.42
▸ CYP1B1 Q16678 1/20 0.42
▸ PTGS1 P23219 2/20 0.41
▸ PTGS2 P35354 2/20 0.41
▸ CA12 O43570 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6271415 0.94 TDP1 (0.45) TDP1L3MBTL1TSHRALDH1A1KDM4E
SCHEMBL6276971 0.91 ALDH1A1 (0.53) TSHRALDH1A1KDM4EMTNR1AMAPT
SCHEMBL6274270 0.91 MGAM (0.56) TDP1L3MBTL1TSHRALDH1A1KDM4E
SCHEMBL6274277 0.91 MGAM (0.56) TDP1L3MBTL1TSHRALDH1A1KDM4E
SCHEMBL6274711 0.87 ACSL1 (0.48) TDP1L3MBTL1TSHRALDH1A1KDM4E
SCHEMBL6277157 0.86 MGAM (0.55) TDP1L3MBTL1TSHRALDH1A1KDM4E
SCHEMBL6277165 0.86 MGAM (0.55) TDP1L3MBTL1TSHRALDH1A1KDM4E
SCHEMBL6277196 0.86 ALDH1A1 (0.52) TDP1L3MBTL1TSHRALDH1A1KDM4E
SCHEMBL6277867 0.85 ALDH1A1 (0.42) TDP1L3MBTL1TSHRALDH1A1KDM4E
SCHEMBL6273114 0.85 NQO1 (0.48) L3MBTL1ALDH1A1KDM4EMAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1273578-B1 Benzopyran derivatives and antiallergic agent containing the same DAINIPPON INK & CHEMICALS (JP) 2005-02-23 — — EP disclosed
CN-1473565-A Benzopyrany/derivatives and antiallergic agent ���ձ���ī��ѧ��ʽ���� 2004-02-11 — — CN disclosed
US-6670391-B2 For inhibiting both immediate and delayed type allergic reactions; side effect reduction DAINIPPON INK AND CHEMICALS, INC. (JP) 2003-12-30 — — US disclosed
US-20030096860-A1 Benzopyran derivative and antiallergic agent DAINIPPON INK AND CHEMICALS, INC. (JP) 2003-05-22 — — US disclosed
EP-1273578-A1 Benzopyran derivatives and antiallergic agent containing the same DAINIPPON INK AND CHEMICALS, INC. (JP) 2003-01-08 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030096860-A1 Benzopyran derivative and antiallergic agent HRH2, HRH1, HRH4 TDP1 2417/4885L3MBTL1 1039/4885TSHR 3189/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback